Table of Content

1 Market Overview of Antiasthmatic Drug
1.1 Antiasthmatic Drug Market Overview
1.1.1 Antiasthmatic Drug Product Scope
1.1.2 Antiasthmatic Drug Market Status and Outlook
1.2 Global Antiasthmatic Drug Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Antiasthmatic Drug Market Size by Region (2024-2034)
1.4 Global Antiasthmatic Drug Historic Market Size by Region (2024-2024)
1.5 Global Antiasthmatic Drug Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Antiasthmatic Drug Market Size (2024-2034)
1.6.1 North America Antiasthmatic Drug Market Size (2024-2034)
1.6.2 Europe Antiasthmatic Drug Market Size (2024-2034)
1.6.3 Asia-Pacific Antiasthmatic Drug Market Size (2024-2034)
1.6.4 Latin America Antiasthmatic Drug Market Size (2024-2034)
1.6.5 Middle East & Africa Antiasthmatic Drug Market Size (2024-2034)
2 Antiasthmatic Drug Market by Type
2.1 Introduction
2.1.1 Bronchodilators
2.1.2 Anti-allergic Antiasthmatic
2.1.3 Anti-inflammatory Antiasthmatic
2.2 Global Antiasthmatic Drug Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Antiasthmatic Drug Historic Market Size by Type (2024-2024)
2.2.2 Global Antiasthmatic Drug Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Antiasthmatic Drug Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Antiasthmatic Drug Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Antiasthmatic Drug Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Antiasthmatic Drug Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Antiasthmatic Drug Revenue Breakdown by Type (2024-2034)
3 Antiasthmatic Drug Market Overview by Application
3.1 Introduction
3.1.1 Need for Acute Attack of Asthma
3.1.2 Treatment of Chronic Asthma
3.2 Global Antiasthmatic Drug Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Antiasthmatic Drug Historic Market Size by Application (2024-2024)
3.2.2 Global Antiasthmatic Drug Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Antiasthmatic Drug Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Antiasthmatic Drug Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Antiasthmatic Drug Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Antiasthmatic Drug Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Antiasthmatic Drug Revenue Breakdown by Application (2024-2034)
4 Antiasthmatic Drug Competition Analysis by Players
4.1 Global Antiasthmatic Drug Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antiasthmatic Drug as of 2022)
4.3 Date of Key Players Enter into Antiasthmatic Drug Market
4.4 Global Top Players Antiasthmatic Drug Headquarters and Area Served
4.5 Key Players Antiasthmatic Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Antiasthmatic Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novartis AG
5.1.1 Novartis AG Profile
5.1.2 Novartis AG Main Business
5.1.3 Novartis AG Antiasthmatic Drug Products, Services and Solutions
5.1.4 Novartis AG Antiasthmatic Drug Revenue (US$ Million) & (2024-2024)
5.1.5 Novartis AG Recent Developments
5.2 GlaxoSmithKline
5.2.1 GlaxoSmithKline Profile
5.2.2 GlaxoSmithKline Main Business
5.2.3 GlaxoSmithKline Antiasthmatic Drug Products, Services and Solutions
5.2.4 GlaxoSmithKline Antiasthmatic Drug Revenue (US$ Million) & (2024-2024)
5.2.5 GlaxoSmithKline Recent Developments
5.3 ABC Farmaceutici Spa
5.3.1 ABC Farmaceutici Spa Profile
5.3.2 ABC Farmaceutici Spa Main Business
5.3.3 ABC Farmaceutici Spa Antiasthmatic Drug Products, Services and Solutions
5.3.4 ABC Farmaceutici Spa Antiasthmatic Drug Revenue (US$ Million) & (2024-2024)
5.3.5 AstraZeneca Recent Developments
5.4 AstraZeneca
5.4.1 AstraZeneca Profile
5.4.2 AstraZeneca Main Business
5.4.3 AstraZeneca Antiasthmatic Drug Products, Services and Solutions
5.4.4 AstraZeneca Antiasthmatic Drug Revenue (US$ Million) & (2024-2024)
5.4.5 AstraZeneca Recent Developments
5.5 Teva Pharmaceutical Industries Ltd
5.5.1 Teva Pharmaceutical Industries Ltd Profile
5.5.2 Teva Pharmaceutical Industries Ltd Main Business
5.5.3 Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Products, Services and Solutions
5.5.4 Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Revenue (US$ Million) & (2024-2024)
5.5.5 Teva Pharmaceutical Industries Ltd Recent Developments
5.6 Mundipharma Pharmaceuticals Ltd.
5.6.1 Mundipharma Pharmaceuticals Ltd. Profile
5.6.2 Mundipharma Pharmaceuticals Ltd. Main Business
5.6.3 Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Products, Services and Solutions
5.6.4 Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Revenue (US$ Million) & (2024-2024)
5.6.5 Mundipharma Pharmaceuticals Ltd. Recent Developments
5.7 MSD
5.7.1 MSD Profile
5.7.2 MSD Main Business
5.7.3 MSD Antiasthmatic Drug Products, Services and Solutions
5.7.4 MSD Antiasthmatic Drug Revenue (US$ Million) & (2024-2024)
5.7.5 MSD Recent Developments
5.8 Daiichi Sankyo Company Limited
5.8.1 Daiichi Sankyo Company Limited Profile
5.8.2 Daiichi Sankyo Company Limited Main Business
5.8.3 Daiichi Sankyo Company Limited Antiasthmatic Drug Products, Services and Solutions
5.8.4 Daiichi Sankyo Company Limited Antiasthmatic Drug Revenue (US$ Million) & (2024-2024)
5.8.5 Daiichi Sankyo Company Limited Recent Developments
5.9 Chiesi GmbH
5.9.1 Chiesi GmbH Profile
5.9.2 Chiesi GmbH Main Business
5.9.3 Chiesi GmbH Antiasthmatic Drug Products, Services and Solutions
5.9.4 Chiesi GmbH Antiasthmatic Drug Revenue (US$ Million) & (2024-2024)
5.9.5 Chiesi GmbH Recent Developments
5.10 Kyorin Pharmaceutical Co.,Ltd.
5.10.1 Kyorin Pharmaceutical Co.,Ltd. Profile
5.10.2 Kyorin Pharmaceutical Co.,Ltd. Main Business
5.10.3 Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Products, Services and Solutions
5.10.4 Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Revenue (US$ Million) & (2024-2024)
5.10.5 Kyorin Pharmaceutical Co.,Ltd. Recent Developments
5.11 Kissei Pharmaceutical Co.Ltd.
5.11.1 Kissei Pharmaceutical Co.Ltd. Profile
5.11.2 Kissei Pharmaceutical Co.Ltd. Main Business
5.11.3 Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Products, Services and Solutions
5.11.4 Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Revenue (US$ Million) & (2024-2024)
5.11.5 Kissei Pharmaceutical Co.Ltd. Recent Developments
5.12 Ruiyang Pharmaceutical Co., Ltd
5.12.1 Ruiyang Pharmaceutical Co., Ltd Profile
5.12.2 Ruiyang Pharmaceutical Co., Ltd Main Business
5.12.3 Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Products, Services and Solutions
5.12.4 Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue (US$ Million) & (2024-2024)
5.12.5 Ruiyang Pharmaceutical Co., Ltd Recent Developments
5.13 Chiesi Pharmaceutical (Shangai) Co., Ltd
5.13.1 Chiesi Pharmaceutical (Shangai) Co., Ltd Profile
5.13.2 Chiesi Pharmaceutical (Shangai) Co., Ltd Main Business
5.13.3 Chiesi Pharmaceutical (Shangai) Co., Ltd Antiasthmatic Drug Products, Services and Solutions
5.13.4 Chiesi Pharmaceutical (Shangai) Co., Ltd Antiasthmatic Drug Revenue (US$ Million) & (2024-2024)
5.13.5 Chiesi Pharmaceutical (Shangai) Co., Ltd Recent Developments
5.14 Fuhe Group
5.14.1 Fuhe Group Profile
5.14.2 Fuhe Group Main Business
5.14.3 Fuhe Group Antiasthmatic Drug Products, Services and Solutions
5.14.4 Fuhe Group Antiasthmatic Drug Revenue (US$ Million) & (2024-2024)
5.14.5 Fuhe Group Recent Developments
5.15 Lunan Pharmaceutical Group Co., Ltd
5.15.1 Lunan Pharmaceutical Group Co., Ltd Profile
5.15.2 Lunan Pharmaceutical Group Co., Ltd Main Business
5.15.3 Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Products, Services and Solutions
5.15.4 Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Revenue (US$ Million) & (2024-2024)
5.15.5 Lunan Pharmaceutical Group Co., Ltd Recent Developments
5.16 Chengdu Huayu Pharmaceutical Co., Ltd
5.16.1 Chengdu Huayu Pharmaceutical Co., Ltd Profile
5.16.2 Chengdu Huayu Pharmaceutical Co., Ltd Main Business
5.16.3 Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Products, Services and Solutions
5.16.4 Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue (US$ Million) & (2024-2024)
5.16.5 Chengdu Huayu Pharmaceutical Co., Ltd Recent Developments
5.17 Kaifeng Kangnuo Pharmaceutical Co., Ltd
5.17.1 Kaifeng Kangnuo Pharmaceutical Co., Ltd Profile
5.17.2 Kaifeng Kangnuo Pharmaceutical Co., Ltd Main Business
5.17.3 Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Products, Services and Solutions
5.17.4 Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue (US$ Million) & (2024-2024)
5.17.5 Kaifeng Kangnuo Pharmaceutical Co., Ltd Recent Developments
5.18 Akorn Pharmaceutical Co.Ltd.
5.18.1 Akorn Pharmaceutical Co.Ltd. Profile
5.18.2 Akorn Pharmaceutical Co.Ltd. Main Business
5.18.3 Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Products, Services and Solutions
5.18.4 Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Revenue (US$ Million) & (2024-2024)
5.18.5 Akorn Pharmaceutical Co.Ltd. Recent Developments
5.19 Boehringer Ingelheim Pharma GmbH&Co.KG
5.19.1 Boehringer Ingelheim Pharma GmbH&Co.KG Profile
5.19.2 Boehringer Ingelheim Pharma GmbH&Co.KG Main Business
5.19.3 Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Products, Services and Solutions
5.19.4 Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Revenue (US$ Million) & (2024-2024)
5.19.5 Boehringer Ingelheim Pharma GmbH&Co.KG Recent Developments
5.20 Covis Pharmaceutical Inc
5.20.1 Covis Pharmaceutical Inc Profile
5.20.2 Covis Pharmaceutical Inc Main Business
5.20.3 Covis Pharmaceutical Inc Antiasthmatic Drug Products, Services and Solutions
5.20.4 Covis Pharmaceutical Inc Antiasthmatic Drug Revenue (US$ Million) & (2024-2024)
5.20.5 Covis Pharmaceutical Inc Recent Developments
5.21 Roche
5.21.1 Roche Profile
5.21.2 Roche Main Business
5.21.3 Roche Antiasthmatic Drug Products, Services and Solutions
5.21.4 Roche Antiasthmatic Drug Revenue (US$ Million) & (2024-2024)
5.21.5 Roche Recent Developments
6 North America
6.1 North America Antiasthmatic Drug Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Antiasthmatic Drug Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Antiasthmatic Drug Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Antiasthmatic Drug Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Antiasthmatic Drug Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Antiasthmatic Drug Market Dynamics
11.1 Antiasthmatic Drug Industry Trends
11.2 Antiasthmatic Drug Market Drivers
11.3 Antiasthmatic Drug Market Challenges
11.4 Antiasthmatic Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Antiasthmatic Drug Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Antiasthmatic Drug Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Antiasthmatic Drug Market Size Share by Region (2024-2024)
Table 4. Global Antiasthmatic Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Antiasthmatic Drug Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Antiasthmatic Drug Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Antiasthmatic Drug Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Antiasthmatic Drug Revenue Market Share by Type (2024-2024)
Table 9. Global Antiasthmatic Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Antiasthmatic Drug Revenue Market Share by Type (2024-2034)
Table 11. North America Antiasthmatic Drug Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Antiasthmatic Drug Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Antiasthmatic Drug Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Antiasthmatic Drug Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Antiasthmatic Drug Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Antiasthmatic Drug Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Antiasthmatic Drug Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Antiasthmatic Drug Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Antiasthmatic Drug Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Antiasthmatic Drug Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Antiasthmatic Drug Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Antiasthmatic Drug Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Antiasthmatic Drug Revenue Market Share by Application (2024-2024)
Table 24. Global Antiasthmatic Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Antiasthmatic Drug Revenue Market Share by Application (2024-2034)
Table 26. North America Antiasthmatic Drug Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Antiasthmatic Drug Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Antiasthmatic Drug Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Antiasthmatic Drug Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Antiasthmatic Drug Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Antiasthmatic Drug Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Antiasthmatic Drug Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Antiasthmatic Drug Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Antiasthmatic Drug Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Antiasthmatic Drug Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Antiasthmatic Drug Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Antiasthmatic Drug Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antiasthmatic Drug as of 2022)
Table 39. Date of Key Players Enter into Antiasthmatic Drug Market
Table 40. Global Antiasthmatic Drug Key Players Headquarters and Area Served
Table 41. Antiasthmatic Drug Product Solution and Service
Table 42. Global Antiasthmatic Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Novartis AG Basic Information List
Table 45. Novartis AG Description and Business Overview
Table 46. Novartis AG Antiasthmatic Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Antiasthmatic Drug Business of Novartis AG (2024-2024)
Table 48. Novartis AG Recent Developments
Table 49. GlaxoSmithKline Basic Information List
Table 50. GlaxoSmithKline Description and Business Overview
Table 51. GlaxoSmithKline Antiasthmatic Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Antiasthmatic Drug Business of GlaxoSmithKline (2024-2024)
Table 53. GlaxoSmithKline Recent Developments
Table 54. ABC Farmaceutici Spa Basic Information List
Table 55. ABC Farmaceutici Spa Description and Business Overview
Table 56. ABC Farmaceutici Spa Antiasthmatic Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Antiasthmatic Drug Business of ABC Farmaceutici Spa (2024-2024)
Table 58. ABC Farmaceutici Spa Recent Developments
Table 59. AstraZeneca Basic Information List
Table 60. AstraZeneca Description and Business Overview
Table 61. AstraZeneca Antiasthmatic Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in Antiasthmatic Drug Business of AstraZeneca (2024-2024)
Table 63. AstraZeneca Recent Developments
Table 64. Teva Pharmaceutical Industries Ltd Basic Information List
Table 65. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 66. Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in Antiasthmatic Drug Business of Teva Pharmaceutical Industries Ltd (2024-2024)
Table 68. Teva Pharmaceutical Industries Ltd Recent Developments
Table 69. Mundipharma Pharmaceuticals Ltd. Basic Information List
Table 70. Mundipharma Pharmaceuticals Ltd. Description and Business Overview
Table 71. Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in Antiasthmatic Drug Business of Mundipharma Pharmaceuticals Ltd. (2024-2024)
Table 73. Mundipharma Pharmaceuticals Ltd. Recent Developments
Table 74. MSD Basic Information List
Table 75. MSD Description and Business Overview
Table 76. MSD Antiasthmatic Drug Products, Services and Solutions
Table 77. Revenue (US$ Million) in Antiasthmatic Drug Business of MSD (2024-2024)
Table 78. MSD Recent Developments
Table 79. Daiichi Sankyo Company Limited Basic Information List
Table 80. Daiichi Sankyo Company Limited Description and Business Overview
Table 81. Daiichi Sankyo Company Limited Antiasthmatic Drug Products, Services and Solutions
Table 82. Revenue (US$ Million) in Antiasthmatic Drug Business of Daiichi Sankyo Company Limited (2024-2024)
Table 83. Daiichi Sankyo Company Limited Recent Developments
Table 84. Chiesi GmbH Basic Information List
Table 85. Chiesi GmbH Description and Business Overview
Table 86. Chiesi GmbH Antiasthmatic Drug Products, Services and Solutions
Table 87. Revenue (US$ Million) in Antiasthmatic Drug Business of Chiesi GmbH (2024-2024)
Table 88. Chiesi GmbH Recent Developments
Table 89. Kyorin Pharmaceutical Co.,Ltd. Basic Information List
Table 90. Kyorin Pharmaceutical Co.,Ltd. Description and Business Overview
Table 91. Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Products, Services and Solutions
Table 92. Revenue (US$ Million) in Antiasthmatic Drug Business of Kyorin Pharmaceutical Co.,Ltd. (2024-2024)
Table 93. Kyorin Pharmaceutical Co.,Ltd. Recent Developments
Table 94. Kissei Pharmaceutical Co.Ltd. Basic Information List
Table 95. Kissei Pharmaceutical Co.Ltd. Description and Business Overview
Table 96. Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Products, Services and Solutions
Table 97. Revenue (US$ Million) in Antiasthmatic Drug Business of Kissei Pharmaceutical Co.Ltd. (2024-2024)
Table 98. Kissei Pharmaceutical Co.Ltd. Recent Developments
Table 99. Ruiyang Pharmaceutical Co., Ltd Basic Information List
Table 100. Ruiyang Pharmaceutical Co., Ltd Description and Business Overview
Table 101. Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Products, Services and Solutions
Table 102. Revenue (US$ Million) in Antiasthmatic Drug Business of Ruiyang Pharmaceutical Co., Ltd (2024-2024)
Table 103. Ruiyang Pharmaceutical Co., Ltd Recent Developments
Table 104. Chiesi Pharmaceutical (Shangai) Co., Ltd Basic Information List
Table 105. Chiesi Pharmaceutical (Shangai) Co., Ltd Description and Business Overview
Table 106. Chiesi Pharmaceutical (Shangai) Co., Ltd Antiasthmatic Drug Products, Services and Solutions
Table 107. Revenue (US$ Million) in Antiasthmatic Drug Business of Chiesi Pharmaceutical (Shangai) Co., Ltd (2024-2024)
Table 108. Chiesi Pharmaceutical (Shangai) Co., Ltd Recent Developments
Table 109. Fuhe Group Basic Information List
Table 110. Fuhe Group Description and Business Overview
Table 111. Fuhe Group Antiasthmatic Drug Products, Services and Solutions
Table 112. Revenue (US$ Million) in Antiasthmatic Drug Business of Fuhe Group (2024-2024)
Table 113. Fuhe Group Recent Developments
Table 114. Lunan Pharmaceutical Group Co., Ltd Basic Information List
Table 115. Lunan Pharmaceutical Group Co., Ltd Description and Business Overview
Table 116. Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Products, Services and Solutions
Table 117. Revenue (US$ Million) in Antiasthmatic Drug Business of Lunan Pharmaceutical Group Co., Ltd (2024-2024)
Table 118. Lunan Pharmaceutical Group Co., Ltd Recent Developments
Table 119. Chengdu Huayu Pharmaceutical Co., Ltd Basic Information List
Table 120. Chengdu Huayu Pharmaceutical Co., Ltd Description and Business Overview
Table 121. Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Products, Services and Solutions
Table 122. Revenue (US$ Million) in Antiasthmatic Drug Business of Chengdu Huayu Pharmaceutical Co., Ltd (2024-2024)
Table 123. Chengdu Huayu Pharmaceutical Co., Ltd Recent Developments
Table 124. Kaifeng Kangnuo Pharmaceutical Co., Ltd Basic Information List
Table 125. Kaifeng Kangnuo Pharmaceutical Co., Ltd Description and Business Overview
Table 126. Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Products, Services and Solutions
Table 127. Revenue (US$ Million) in Antiasthmatic Drug Business of Kaifeng Kangnuo Pharmaceutical Co., Ltd (2024-2024)
Table 128. Kaifeng Kangnuo Pharmaceutical Co., Ltd Recent Developments
Table 129. Akorn Pharmaceutical Co.Ltd. Basic Information List
Table 130. Akorn Pharmaceutical Co.Ltd. Description and Business Overview
Table 131. Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Products, Services and Solutions
Table 132. Revenue (US$ Million) in Antiasthmatic Drug Business of Akorn Pharmaceutical Co.Ltd. (2024-2024)
Table 133. Akorn Pharmaceutical Co.Ltd. Recent Developments
Table 134. Boehringer Ingelheim Pharma GmbH&Co.KG Basic Information List
Table 135. Boehringer Ingelheim Pharma GmbH&Co.KG Description and Business Overview
Table 136. Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Products, Services and Solutions
Table 137. Revenue (US$ Million) in Antiasthmatic Drug Business of Boehringer Ingelheim Pharma GmbH&Co.KG (2024-2024)
Table 138. Boehringer Ingelheim Pharma GmbH&Co.KG Recent Developments
Table 139. Covis Pharmaceutical Inc Basic Information List
Table 140. Covis Pharmaceutical Inc Description and Business Overview
Table 141. Covis Pharmaceutical Inc Antiasthmatic Drug Products, Services and Solutions
Table 142. Revenue (US$ Million) in Antiasthmatic Drug Business of Covis Pharmaceutical Inc (2024-2024)
Table 143. Covis Pharmaceutical Inc Recent Developments
Table 144. Roche Basic Information List
Table 145. Roche Description and Business Overview
Table 146. Roche Antiasthmatic Drug Products, Services and Solutions
Table 147. Revenue (US$ Million) in Antiasthmatic Drug Business of Roche (2024-2024)
Table 148. Roche Recent Developments
Table 149. North America Antiasthmatic Drug Market Size by Country (2024-2024) & (US$ Million)
Table 150. North America Antiasthmatic Drug Market Size by Country (2024-2034) & (US$ Million)
Table 151. Europe Antiasthmatic Drug Market Size by Country (2024-2024) & (US$ Million)
Table 152. Europe Antiasthmatic Drug Market Size by Country (2024-2034) & (US$ Million)
Table 153. Asia-Pacific Antiasthmatic Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 154. Asia-Pacific Antiasthmatic Drug Market Size by Region (2024-2024) & (US$ Million)
Table 155. Asia-Pacific Antiasthmatic Drug Market Size by Region (2024-2034) & (US$ Million)
Table 156. Asia-Pacific Antiasthmatic Drug Market Share by Region (2024-2024)
Table 157. Asia-Pacific Antiasthmatic Drug Market Share by Region (2024-2034)
Table 158. Latin America Antiasthmatic Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 159. Latin America Antiasthmatic Drug Market Size by Country (2024-2024) & (US$ Million)
Table 160. Latin America Antiasthmatic Drug Market Size by Country (2024-2034) & (US$ Million)
Table 161. Middle East & Africa Antiasthmatic Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 162. Middle East & Africa Antiasthmatic Drug Market Size by Country (2024-2024) & (US$ Million)
Table 163. Middle East & Africa Antiasthmatic Drug Market Size by Country (2024-2034) & (US$ Million)
Table 164. Antiasthmatic Drug Market Trends
Table 165. Antiasthmatic Drug Market Drivers
Table 166. Antiasthmatic Drug Market Challenges
Table 167. Antiasthmatic Drug Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiasthmatic Drug Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Antiasthmatic Drug Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Antiasthmatic Drug Market Share by Regions: 2022 VS 2034
Figure 4. Global Antiasthmatic Drug Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Antiasthmatic Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Antiasthmatic Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Antiasthmatic Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Antiasthmatic Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Antiasthmatic Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Bronchodilators
Figure 11. Global Bronchodilators Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Anti-allergic Antiasthmatic
Figure 13. Global Anti-allergic Antiasthmatic Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Anti-inflammatory Antiasthmatic
Figure 15. Global Anti-inflammatory Antiasthmatic Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Global Antiasthmatic Drug Market Size Share by Type: 2022 & 2034
Figure 17. North America Antiasthmatic Drug Revenue Market Share by Type (2024-2034)
Figure 18. Europe Antiasthmatic Drug Revenue Market Share by Type (2024-2034)
Figure 19. Asia-Pacific Antiasthmatic Drug Revenue Market Share by Type (2024-2034)
Figure 20. Latin America Antiasthmatic Drug Revenue Market Share by Type (2024-2034)
Figure 21. Middle East and Africa Antiasthmatic Drug Revenue Market Share by Type (2024-2034)
Figure 22. Need for Acute Attack of Asthma Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Treatment of Chronic Asthma Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Global Antiasthmatic Drug Market Size Share by Application: 2022 & 2034
Figure 25. North America Antiasthmatic Drug Revenue Market Share by Application (2024-2034)
Figure 26. Europe Antiasthmatic Drug Revenue Market Share by Application (2024-2034)
Figure 27. Asia-Pacific Antiasthmatic Drug Revenue Market Share by Application (2024-2034)
Figure 28. Latin America Antiasthmatic Drug Revenue Market Share by Application (2024-2034)
Figure 29. Middle East and Africa Antiasthmatic Drug Revenue Market Share by Application (2024-2034)
Figure 30. Antiasthmatic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 31. Global Top 5 and Top 10 Players Antiasthmatic Drug Market Share in 2022
Figure 32. North America Antiasthmatic Drug Market Share by Country (2024-2034)
Figure 33. United States Antiasthmatic Drug Market Size (2024-2034) & (US$ Million)
Figure 34. Canada Antiasthmatic Drug Market Size (2024-2034) & (US$ Million)
Figure 35. Germany Antiasthmatic Drug Market Size (2024-2034) & (US$ Million)
Figure 36. France Antiasthmatic Drug Market Size (2024-2034) & (US$ Million)
Figure 37. U.K. Antiasthmatic Drug Market Size (2024-2034) & (US$ Million)
Figure 38. Italy Antiasthmatic Drug Market Size (2024-2034) & (US$ Million)
Figure 39. Russia Antiasthmatic Drug Market Size (2024-2034) & (US$ Million)
Figure 40. Nordic Countries Antiasthmatic Drug Market Size (2024-2034) & (US$ Million)
Figure 41. Asia-Pacific Antiasthmatic Drug Market Share by Region (2024-2034)
Figure 42. China Antiasthmatic Drug Market Size (2024-2034) & (US$ Million)
Figure 43. Japan Antiasthmatic Drug Market Size (2024-2034) & (US$ Million)
Figure 44. South Korea Antiasthmatic Drug Market Size (2024-2034) & (US$ Million)
Figure 45. Southeast Asia Antiasthmatic Drug Market Size (2024-2034) & (US$ Million)
Figure 46. India Antiasthmatic Drug Market Size (2024-2034) & (US$ Million)
Figure 47. Australia Antiasthmatic Drug Market Size (2024-2034) & (US$ Million)
Figure 48. Latin America Antiasthmatic Drug Market Share by Country (2024-2034)
Figure 49. Mexico Antiasthmatic Drug Market Size (2024-2034) & (US$ Million)
Figure 50. Brazil Antiasthmatic Drug Market Size (2024-2034) & (US$ Million)
Figure 51. Middle East & Africa Antiasthmatic Drug Market Share by Country (2024-2034)
Figure 52. Turkey Antiasthmatic Drug Market Size (2024-2034) & (US$ Million)
Figure 53. Saudi Arabia Antiasthmatic Drug Market Size (2024-2034) & (US$ Million)
Figure 54. UAE Antiasthmatic Drug Market Size (2024-2034) & (US$ Million)
Figure 55. Bottom-up and Top-down Approaches for This Report